These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 22387675)
1. Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. Aoi M; Date I; Tomita S; Ohmoto T Restor Neurol Neurosci; 2000 Jan; 17(1):31-8. PubMed ID: 22387675 [TBL] [Abstract][Full Text] [Related]
2. Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. Aoi M; Date I; Tomita S; Ohmoto T Restor Neurol Neurosci; 2001 Aug; 17(1):31-38. PubMed ID: 11490075 [TBL] [Abstract][Full Text] [Related]
3. The effect of intrastriatal single injection of GDNF on the nigrostriatal dopaminergic system in hemiparkinsonian rats: behavioral and histological studies using two different dosages. Aoi M; Date I; Tomita S; Ohmoto T Neurosci Res; 2000 Apr; 36(4):319-25. PubMed ID: 10771110 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of glial cell line-derived neurotrophic factor (GDNF) in the striatum and substantia nigra of the aged Parkinsonian rat. Connor B; Kozlowski DA; Schallert T; Tillerson JL; Davidson BL; Bohn MC Gene Ther; 1999 Dec; 6(12):1936-51. PubMed ID: 10637445 [TBL] [Abstract][Full Text] [Related]
5. Behavioral and cellular protection of rat dopaminergic neurons by an adenoviral vector encoding glial cell line-derived neurotrophic factor. Choi-Lundberg DL; Lin Q; Schallert T; Crippens D; Davidson BL; Chang YN; Chiang YL; Qian J; Bardwaj L; Bohn MC Exp Neurol; 1998 Dec; 154(2):261-75. PubMed ID: 9878166 [TBL] [Abstract][Full Text] [Related]
8. Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease. Zheng JS; Tang LL; Zheng SS; Zhan RY; Zhou YQ; Goudreau J; Kaufman D; Chen AF Brain Res Mol Brain Res; 2005 Mar; 134(1):155-61. PubMed ID: 15790539 [TBL] [Abstract][Full Text] [Related]
9. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Tomac A; Lindqvist E; Lin LF; Ogren SO; Young D; Hoffer BJ; Olson L Nature; 1995 Jan; 373(6512):335-9. PubMed ID: 7830766 [TBL] [Abstract][Full Text] [Related]
10. Dopamine D1 and D2 receptor-mediated acute and long-lasting behavioral effects of glial cell line-derived neurotrophic factor administered into the striatum. Kobayashi S; Ogren SO; Hoffer BJ; Olson L Exp Neurol; 1998 Dec; 154(2):302-14. PubMed ID: 9878169 [TBL] [Abstract][Full Text] [Related]
11. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. Sanchez B; Relova JL; Gallego R; Ben-Batalla I; Perez-Fernandez R J Neurosci Res; 2009 Feb; 87(3):723-32. PubMed ID: 18816795 [TBL] [Abstract][Full Text] [Related]
12. Intrastriatal injection of sonic hedgehog reduces behavioral impairment in a rat model of Parkinson's disease. Tsuboi K; Shults CW Exp Neurol; 2002 Jan; 173(1):95-104. PubMed ID: 11771942 [TBL] [Abstract][Full Text] [Related]
13. Continuous exposure to glial cell line-derived neurotrophic factor to mature dopaminergic transplants impairs the graft's ability to improve spontaneous motor behavior in parkinsonian rats. Winkler C; Georgievska B; Carlsson T; Lacar B; Kirik D Neuroscience; 2006 Aug; 141(1):521-31. PubMed ID: 16697115 [TBL] [Abstract][Full Text] [Related]
14. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model. Rosenblad C; Kirik D; Björklund A Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072 [TBL] [Abstract][Full Text] [Related]
15. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections. Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and restorative effects of intrastriatal grafting of encapsulated GDNF-producing cells in a rat model of Parkinson's disease. Shingo T; Date I; Yoshida H; Ohmoto T J Neurosci Res; 2002 Sep; 69(6):946-54. PubMed ID: 12205688 [TBL] [Abstract][Full Text] [Related]
18. Glial cell-line derived neurotrophic factor is essential for electroconvulsive shock-induced neuroprotection in an animal model of Parkinson's disease. Anastasía A; Wojnacki J; de Erausquin GA; Mascó DH Neuroscience; 2011 Nov; 195():100-11. PubMed ID: 21871541 [TBL] [Abstract][Full Text] [Related]
19. Protection of dopaminergic nigrostriatal afferents by GDNF delivered by microspheres in a rodent model of Parkinson's disease. Gouhier C; Chalon S; Aubert-Pouessel A; Venier-Julienne MC; Jollivet C; Benoit JP; Guilloteau D Synapse; 2002 Jun; 44(3):124-31. PubMed ID: 11954043 [TBL] [Abstract][Full Text] [Related]
20. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease. Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]